Risk for incident chronic kidney disease (eGFR ≤ 60 ml/min per 1.73 m2) at follow-up re-examination in 2851 participants of the Malmö Diet and Cancer Study-Cardiovascular Cohort according to the quartile of suPAR concentration at baseline. The logistic regression model was adjusted for age, sex, baseline levels of eGFR, fasting glucose, body mass index, systolic blood pressure, antihypertensive treatment (yes/no), smoking (current, ex, former), and follow-up time. Concentration of suPAR at baseline Q1: 0.03–2.35, Q2: 2.35–2.70, Q3: 2.71–3.25, and Q4: 3.25–15.64. N/cases: Q1: 712/94, Q2: 713/132, Q3: 713/163, and Q4: 713/172. CI, confidence interval; eGFR, estimated glomerular filtration rate according to the Chronic Kidney Disease Epidemiology Collaboration creatinine equation23; OR, odds ratio; suPAR, soluble urokinase-type plasminogen activator receptor.